Warning! The directory is not yet complete and will be amended until the beginning of the term.
301407 VO DNA-Tumor Viruses, from Cancer Agent to therapy (2023W)
Elective Course in Molecular Medicine
Labels
ON-SITE
Registration/Deregistration
Note: The time of your registration within the registration period has no effect on the allocation of places (no first come, first served).
Details
Language: English
Examination dates
- Tuesday 19.12.2023 10:00 - 11:00 BZB/Seminarraum 1/2, 6.Ebene 6.501/6.504, Dr.-Bohr-Gasse 9, 1030 Wien
- Tuesday 23.01.2024
- Friday 22.03.2024 11:00 - 12:00 BZB/Seminarraum 1/2, 6.Ebene 6.501/6.504, Dr.-Bohr-Gasse 9, 1030 Wien
- Monday 24.06.2024 11:00 - 12:00 BZB/Seminarraum 1/2, 6.Ebene 6.501/6.504, Dr.-Bohr-Gasse 9, 1030 Wien
Lecturers
Classes
Lectures:
October 31st, November 7th, 13th, 27th, December 4th and 5th
3-5pm Seminarroom 1, Floor 6
Information
Aims, contents and method of the course
Assessment and permitted materials
Written exam
Minimum requirements and assessment criteria
Maximum points: 40. Usually 4 questions, 10 points/question
Grading key: <20= 5 (insufficient); 20-24 = 4 (sufficient); 25-29 = 3 (satisfactory); 30-34 = 2 (good); 35-40 = 1 (very good)
Grading key: <20= 5 (insufficient); 20-24 = 4 (sufficient); 25-29 = 3 (satisfactory); 30-34 = 2 (good); 35-40 = 1 (very good)
Examination topics
Content of the course. Lectures in English, exam in English. Questions can also be answered in German
Reading list
Course documents in Moodle. Information on the literature available on the slides in Moodle.
Association in the course directory
MMB IV-2, MMB IV-3, MMB W-2, MMEI III, UF MA BU 01, UF MA BU 04
Last modified: Fr 24.05.2024 14:46
The lecture will include the following topics:
Classification of DNA tumour viruses
Lytic and transformation cycle
Viral oncoproteins and their cellular targets: p53, pRB (the retinoblastoma gene product), protein phosphatase 2A (PP2A) and others
Human Papillomavirus and the development of cervical carcinoma
Cancer therapy with adenovirus mutants